Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 16;32(1):192-200.e6.
doi: 10.1016/j.chembiol.2024.10.007. Epub 2024 Nov 12.

Degradome analysis to identify direct protein substrates of small-molecule degraders

Affiliations
Free article

Degradome analysis to identify direct protein substrates of small-molecule degraders

Marco Jochem et al. Cell Chem Biol. .
Free article

Abstract

Targeted protein degradation (TPD) has emerged as a powerful strategy to selectively eliminate cellular proteins using small-molecule degraders, offering therapeutic promise for targeting proteins that are otherwise undruggable. However, a remaining challenge is to unambiguously identify primary TPD targets that are distinct from secondary downstream effects in the proteome. Here we introduce an approach for selective analysis of protein degradation by mass spectrometry (DegMS) at proteomic scale, which derives its specificity from the exclusion of confounding effects of altered transcription and translation induced by target depletion. We show that the approach efficiently operates at the timescale of TPD (hours) and we demonstrate its utility by analyzing the cyclin K degraders dCeMM2 and dCeMM4, which induce widespread transcriptional downregulation, and the GSPT1 degrader CC-885, an inhibitor of protein translation. Additionally, we apply DegMS to characterize a previously uncharacterized degrader, and identify the zinc-finger protein FIZ1 as a degraded target.

Keywords: PROTAC; click chemistry; molecular glue; protein degradation; proteomics; stable isotope labeling; targeted protein degradation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests G.E.W. is scientific founder and shareholder of Proxygen and Solgate. The Winter lab received funding from Pfizer.

Substances

LinkOut - more resources